4//SEC Filing
KENYON LAWRENCE A 4
Accession 0001209191-20-043224
CIK 0001649989other
Filed
Jul 20, 8:00 PM ET
Accepted
Jul 21, 6:09 PM ET
Size
5.8 KB
Accession
0001209191-20-043224
Insider Transaction Report
Form 4
KENYON LAWRENCE A
CFO and Secretary
Transactions
- Award
Stock Option (Right to Buy)
2020-07-17+450,000→ 450,000 totalExercise: $1.58Exp: 2030-07-17→ Common Stock (450,000 underlying)
Footnotes (1)
- [F1]The options were granted under the Issuer's 2015 Equity Incentive Plan (the "2015 Plan") and shall vest in four equal installments beginning on July 17, 2021 such that the option shall be vested in full on July 17, 2024, subject to the Reporting Person providing continuous service to the Issuer on each such date, and subject to acceleration upon a Change in Control as defined in the 2015 Plan, subject to the Reporting Person providing continuous service to the Issuer through such event.
Documents
Issuer
Outlook Therapeutics, Inc.
CIK 0001649989
Entity typeother
Related Parties
1- filerCIK 0001230484
Filing Metadata
- Form type
- 4
- Filed
- Jul 20, 8:00 PM ET
- Accepted
- Jul 21, 6:09 PM ET
- Size
- 5.8 KB